ALZHEIMER’S PREVENTION & TREATMENT PROTOCOL FOR ALL STAGES OF ALZHEIMER’S
6-8-10
INTRODUCTION
To date, researchers do not know, or have not revealed, the root cause of Alzheimer’s. The root cause is present every time Alzheimer’s occurs--and, every time Alzheimer’s occurs, the root cause is present.
The following Alzheimer’s treatment and prevention Protocol was invented by an Iowalive net worker, using Iowalive’s proprietary algorithms and data base. The Protocol is generously provided to all, at no cost or obligation to anyone. The inventor, experienced at solving the most difficult problems, has no intention to file for a patent--but rather hopes for wide use of the Protocol. It is ready for trial testing, or trial use, and people are welcome to support such tests, or use, as desired--at their discretion.
The inventor receives no compensation or benefits from the producers of products suggested in the Protocol. Similarly, the inventor, and the nutrient supplement manufacturers, do not prescribe or make any specific health claims for the Protocol. Should anyone require medical advice for any health reason, they should consult their doctors and medical care providers.
It is the sole intent of the Protocol to synergize a thoroughly researched group of commonly used nutrients to prevent and halt progression of Alzheimer’s.
THE ROOT CAUSE OF ALZHEIMER’S
The inventor finds the root cause of Alzheimer’s to be a long term, 20% deficiency in *iron and in about 3% of the cases, also a 30% deficiency in selenium. Unfortunately, the inventor strongly suspects these deficiency levels might not be noticed or even detected with available deficiency testing methods. This suspicion can be resolved by testing Alzheimer’s patients for iron deficiencies--using the best testing methods available. If no iron deficiencies in patients are detected, supplementation with the one or both nutrients can commence to determine if symptoms are reduced.
If you enter Alzheimer’s, iron and selenium in a GOOGLE search, you will find about 98,700 references. The linkage of iron and selenium with successfully treating Alzheimer’s is not new to those outside the medical and pharmaceutical establishments.
The inventor has no knowledge of any side effects from the levels of common nutrients used in the Protocol. The products have been competitively marketed, likely for many years, without any known complaints from users.
However, the many side effects of commonly accepted Alzheimer’s drugs, prescribed by doctors, are respectively described on website:
http://www.healingwithnutrition.com/adisease/alzheimers/alzheimersdrugs.html
Total cost of the off-the-shelf products in the Protocol is less than $25, including shipping costs. This alone has likely discouraged Alzheimer’s researchers and pharmaceutical companies from pursuing a nutritionally based treatment for Alzheimer’s.
SUGGESTED ALZHEIMER’S TREATMENT PROTOCOL
REMOVE DEFICIENCIES IN IRON AND SELENIUM
FOLLOW-UP
AFTER 6 WEEKS, TEST FOR EVIDENCE OF IMPROVEMENT. IF SYMPTOMS ARE GONE, CONTINUATION OF PROTOCOL IS OPTIONAL.
IF ANY SYMPTOMS ARE DETECTED, CONTINUE PROTOCOL FOR 6 MORE WEEKS. CONTINUE TEST AND TREATMENT PROTOCOL CYCLE UNTIL NO SYMPTOMS ARE DETECTED IN PATIENT. THEN TEST FOR SYMPTOMS ANNUALLY. FOR PREVENTATIVE TREATMENT, THE SELENIUM COULD LIKELY BE TAKEN FOR LONG PERIODS OF TIME BUT THE IRON CAN BE TOXIC IF OVERDOSED, WHICH IS UNLIKELY FOR MOST PEOPLE, WHEN ONLY 1 TABLE T IS TAKEN EVERY OTHER DAY.
RESULTS EXPECTATIONS
70% OF EARLY OR MILD ALZHEIMER’S CASE PATIENTS WILL HAVE THEIR CONDITION REVERSED. IN ADDITION, ABOUT 80% OF THE MODERATE AND SERVER CASES WILL BE HALTED OR SLOWED. NO ADVERSE SIDE EFFECTS ARE EXPECTED. TOTAL SUPPLEMENT COST PER PATIENT IS LESS THAN $25, SINCE ALL ARE AVAILABLE OFF-THE-SHELF.
CLOSURE
THIS PROTOCOL IS SUBJECT TO REFINEMENT, BASED ON RESULTS OF EXTENSIVE USE.
USE OF THIS PROTOCOL SHOULD ALSO BE EFFECTIVE WHEN USED IN CONJUNCTION WITH OTHER ALZHEIMER’S TREATMENTS—WITHOUT CONFLICTS OR SIDE AFFECTS.
*NOTICE REGARDING NEED FOR IRON TO TREAT ALZHEIMER’S
Some researchers have found small particles of iron in the brains of some Alzheimer’s patients and have concluded that an excess of iron can cause the disease, ref. website: http://www.webmd.com/news/20000228/high-iron-levels-identified-in-brains-of-alzheimers-patients . Our research and analysis has shown just the opposite, and here is why.
While it is true that some patients do indeed have particles of iron in their brains, why it is deposited there has yet to be fully determined. We find it is there because it is not assimilated and the body has found no better place for it. Dietary tannic acid (TA) inhibits iron absorption and contributes to the problem. We further find that ferrous fumerate, included in the Protocol, is a very readily assimilated iron supplement--that is not likely to be inhibited by tannic acid. It is strongly suspected that Alzheimer’s can be caused by a long term, undetectable deficiency in iron—and a detectable deficiency in selenium. That is a formidable problem for other researchers to overcome--to discover the cause, prevention and effective treatment of Alzheimer’s.
Symptoms and signs of detectable iron deficiency are presented on website: http://en.wikipedia.org/wiki/Iron_deficiency_anemia
It is Iowalive's policy not to cite successes for the above protocol, nor testimonials from those successfully using the protocol.